{"id":54050,"date":"2023-02-17T16:03:19","date_gmt":"2023-02-17T15:03:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/"},"modified":"2023-02-17T16:03:19","modified_gmt":"2023-02-17T15:03:19","slug":"strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/","title":{"rendered":"Stryker\u2019s Q Guidance System for cranial applications receives FDA clearance"},"content":{"rendered":"
\n

\nCranial Guidance Software offers surgeons robust imaging and guidance during cranial procedures<\/i>\n<\/p>\n

KALAMAZOO, Mich.–(BUSINESS WIRE)–Stryker (NYSE:SYK), one of the world\u2019s leading medical technology companies, today announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from the U.S. Food and Drug Administration. The Q Guidance System is an image-based planning and intraoperative guidance system designed to support cranial surgeries. Recently launched<\/a> in September 2022, the Q Guidance System for spinal applications is currently available on the market.\n<\/p>\n

<\/a><\/p>\n

\nThe Q Guidance System with Cranial Guidance Software is indicated for any medical condition in which the use of computer-assisted planning and surgery may be appropriate and can be used for intraoperative guidance where a reference to a rigid anatomical structure can be identified. It tracks navigated instruments and displays the position and orientation of the instruments in patient images. The Cranial Guidance Software includes automatic, algorithmic processing and comprehensive guidance data that aim to elevate confidence and surgical ability.\n<\/p>\n

\n\u201cThe FDA clearance of Stryker\u2019s Q Guidance System with Cranial Guidance Software is a key milestone, which will help lead the transformation of cranial navigation and surgery,\u201d said Robbie Robinson, president of Stryker\u2019s Spine division. \u201cOur robust pipeline of iterative launches reinforces our commitment to making industry-leading investments focused on providing advanced navigation products and differentiated technologies that our surgeon customers have come to expect.\u201d\n<\/p>\n

\nThe Cranial Guidance Software is powered by Stryker\u2019s Q Guidance System and can be used with a range of instruments and accessories for navigated cranial procedures. New for brain biopsies, the software provides a dedicated workflow to support the accurate alignment of the Precision Targeting System with a pre-operatively planned approach. Stryker is also leveraging plug-in EM tracking technology that can be used with both adults and pediatric patients for the placement of shunt catheters, which can be visualized with an EM Stylet.\n<\/p>\n

\nAbout Stryker<\/b>\n<\/p>\n

\nStryker is one of the world\u2019s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Medical and Surgical, Neurotechnology, Orthopaedics and Spine that help improve patient and healthcare outcomes. Alongside its customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAndrea Sampson, Sampson Public Relations Group
\n
562 304 0301
\n
asampson@sampsonprgroup.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Cranial Guidance Software offers surgeons robust imaging and guidance during cranial procedures KALAMAZOO, Mich.–(BUSINESS WIRE)–Stryker (NYSE:SYK), one of the world\u2019s leading medical technology companies, today announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from the U.S. Food and Drug Administration. The Q Guidance System is an image-based planning and intraoperative … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-54050","6":"format-standard","7":"category-industry"},"yoast_head":"\nStryker\u2019s Q Guidance System for cranial applications receives FDA clearance - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Stryker\u2019s Q Guidance System for cranial applications receives FDA clearance - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Cranial Guidance Software offers surgeons robust imaging and guidance during cranial procedures KALAMAZOO, Mich.–(BUSINESS WIRE)–Stryker (NYSE:SYK), one of the world\u2019s leading medical technology companies, today announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from the U.S. Food and Drug Administration. The Q Guidance System is an image-based planning and intraoperative ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-17T15:03:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230217005102\/en\/1716706\/21\/Stryker.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Stryker\u2019s Q Guidance System for cranial applications receives FDA clearance\",\"datePublished\":\"2023-02-17T15:03:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/\"},\"wordCount\":404,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230217005102\\\/en\\\/1716706\\\/21\\\/Stryker.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/\",\"name\":\"Stryker\u2019s Q Guidance System for cranial applications receives FDA clearance - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230217005102\\\/en\\\/1716706\\\/21\\\/Stryker.jpg\",\"datePublished\":\"2023-02-17T15:03:19+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230217005102\\\/en\\\/1716706\\\/21\\\/Stryker.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230217005102\\\/en\\\/1716706\\\/21\\\/Stryker.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Stryker\u2019s Q Guidance System for cranial applications receives FDA clearance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Stryker\u2019s Q Guidance System for cranial applications receives FDA clearance - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/","og_locale":"en_US","og_type":"article","og_title":"Stryker\u2019s Q Guidance System for cranial applications receives FDA clearance - Pharma Trend","og_description":"Cranial Guidance Software offers surgeons robust imaging and guidance during cranial procedures KALAMAZOO, Mich.–(BUSINESS WIRE)–Stryker (NYSE:SYK), one of the world\u2019s leading medical technology companies, today announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from the U.S. Food and Drug Administration. The Q Guidance System is an image-based planning and intraoperative ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-17T15:03:19+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230217005102\/en\/1716706\/21\/Stryker.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Stryker\u2019s Q Guidance System for cranial applications receives FDA clearance","datePublished":"2023-02-17T15:03:19+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/"},"wordCount":404,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230217005102\/en\/1716706\/21\/Stryker.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/","url":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/","name":"Stryker\u2019s Q Guidance System for cranial applications receives FDA clearance - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230217005102\/en\/1716706\/21\/Stryker.jpg","datePublished":"2023-02-17T15:03:19+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230217005102\/en\/1716706\/21\/Stryker.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230217005102\/en\/1716706\/21\/Stryker.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/strykers-q-guidance-system-for-cranial-applications-receives-fda-clearance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Stryker\u2019s Q Guidance System for cranial applications receives FDA clearance"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54050","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=54050"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/54050\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=54050"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=54050"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=54050"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}